These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15670945)

  • 1. On the role of E-ring oxygen atoms in the binding of camptothecin to the topoisomerase I-DNA covalent binary complex.
    Rahier NJ; Eisenhauer BM; Gao R; Thomas SJ; Hecht SM
    Bioorg Med Chem; 2005 Feb; 13(4):1381-6. PubMed ID: 15670945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the 20-hydroxyl group in camptothecin binding by the topoisomerase I-DNA binary complex.
    Wang X; Zhou X; Hecht SM
    Biochemistry; 1999 Apr; 38(14):4374-81. PubMed ID: 10194356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 14-azacamptothecin: a potent water-soluble topoisomerase I poison.
    Cheng K; Rahier NJ; Eisenhauer BM; Gao R; Thomas SJ; Hecht SM
    J Am Chem Soc; 2005 Jan; 127(3):838-9. PubMed ID: 15656613
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential effects of camptothecin derivatives on topoisomerase I-mediated DNA structure modification.
    Wang X; Wang LK; Kingsbury WD; Johnson RK; Hecht SM
    Biochemistry; 1998 Jun; 37(26):9399-408. PubMed ID: 9649322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Luotonin A. A naturally occurring human DNA topoisomerase I poison.
    Cagir A; Jones SH; Gao R; Eisenhauer BM; Hecht SM
    J Am Chem Soc; 2003 Nov; 125(45):13628-9. PubMed ID: 14599178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Water-soluble camptothecin derivatives that are intrinsic topoisomerase I poisons.
    Rahier NJ; Eisenhauer BM; Gao R; Jones SH; Hecht SM
    Org Lett; 2004 Feb; 6(3):321-4. PubMed ID: 14748583
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of modification of the active site tyrosine of human DNA topoisomerase I.
    Gao R; Zhang Y; Dedkova L; Choudhury AK; Rahier NJ; Hecht SM
    Biochemistry; 2006 Jul; 45(27):8402-10. PubMed ID: 16819839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of camptothecin analogues on DNA transformations mediated by calf thymus and human DNA topoisomerases I.
    Wang X; Short GF; Kingsbury WD; Johnson RK; Hecht SM
    Chem Res Toxicol; 1998 Nov; 11(11):1352-60. PubMed ID: 9815197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and topoisomerase poisoning activity of A-ring and E-ring substituted luotonin A derivatives.
    Nacro K; Zha CC; Guzzo PR; Jason Herr R; Peace D; Friedrich TD
    Bioorg Med Chem; 2007 Jun; 15(12):4237-46. PubMed ID: 17418582
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Action models for the antitumor drug camptothecin: formation of alkali-labile complex with DNA and inhibition of human DNA topoisomerase I.
    Streltsov SA
    J Biomol Struct Dyn; 2002 Dec; 20(3):447-54. PubMed ID: 12437383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SUMO-1 conjugation to intact DNA topoisomerase I amplifies cleavable complex formation induced by camptothecin.
    Horie K; Tomida A; Sugimoto Y; Yasugi T; Yoshikawa H; Taketani Y; Tsuruo T
    Oncogene; 2002 Nov; 21(52):7913-22. PubMed ID: 12439742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Camptothecins inhibit the utilization of hydrogen peroxide in the ligation step of topoisomerase I catalysis.
    Lisby M; Krogh BO; Boege F; Westergaard O; Knudsen BR
    Biochemistry; 1998 Jul; 37(30):10815-27. PubMed ID: 9692972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrophilic camptothecin analogs that form extremely stable cleavable complexes with DNA and topoisomerase I.
    Wadkins RM; Bearss D; Manikumar G; Wani MC; Wall ME; Von Hoff DD
    Cancer Res; 2004 Sep; 64(18):6679-83. PubMed ID: 15374984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of E-ring modifications in camptothecin on topoisomerase I inhibition: a quantum mechanics treatment.
    Xiao X; Cushman M
    J Org Chem; 2005 Nov; 70(23):9584-7. PubMed ID: 16268636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistence of camptothecin analog-topoisomerase I-DNA ternary complexes: a molecular dynamics study.
    Siu FM; Che CM
    J Am Chem Soc; 2008 Dec; 130(52):17928-37. PubMed ID: 19035632
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthocyanidins modulate the activity of human DNA topoisomerases I and II and affect cellular DNA integrity.
    Habermeyer M; Fritz J; Barthelmes HU; Christensen MO; Larsen MK; Boege F; Marko D
    Chem Res Toxicol; 2005 Sep; 18(9):1395-404. PubMed ID: 16167831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Camptothecin: current perspectives.
    Thomas CJ; Rahier NJ; Hecht SM
    Bioorg Med Chem; 2004 Apr; 12(7):1585-604. PubMed ID: 15028252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DNA topoisomerase I inhibitors from Rinorea anguifera.
    Ma J; Jones SH; Marshall R; Wu X; Hecht SM
    Bioorg Med Chem Lett; 2005 Feb; 15(3):813-6. PubMed ID: 15664863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of camptothecin resistance by human topoisomerase I mutations.
    Chrencik JE; Staker BL; Burgin AB; Pourquier P; Pommier Y; Stewart L; Redinbo MR
    J Mol Biol; 2004 Jun; 339(4):773-84. PubMed ID: 15165849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biological properties of IDN5174, a new synthetic camptothecin with the open lactone ring.
    Beretta GL; Petrangolini G; De Cesare M; Pratesi G; Perego P; Tinelli S; Tortoreto M; Zucchetti M; Frapolli R; Bello E; Manzotti C; Fontana G; Bombardelli E; Battaglia A; Samorì C; Zunino F
    Cancer Res; 2006 Nov; 66(22):10976-82. PubMed ID: 17108136
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.